Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

NSE/NGLFINE stock hub

NSE/NGLFINE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/NGLFINEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.5B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/NGLFINE

In the news

Latest news · NSE/NGLFINE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E41

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC9.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/NGLFINE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

INR

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	520
Employees Change	-162%
Employees Change Percent	-23.75
Enterprise value	INR 14.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	INE887E01022
Last refreshed	2026-05-10
Market cap	INR 14.5B
Price	INR 2,365
Price currency	INR
Rev Per Employee	8,592,451.92x
Sector	Healthcare
Sic	2833
Symbol	nse/NGLFINE
Website	https://www.nglfinechem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.44%
EV Earnings	41.9x
EV/EBIT	36.97x
EV/EBITDA	27.96x
EV/Sales	3.32x
P/B ratio	4.83x
P/E ratio	40.99x
P/S ratio	3.25x
PE Ratio10 Y	24.64x
PE Ratio3 Y	34.12x
PE Ratio5 Y	32.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.97%
EBITDA Margin	11.86%
Gross margin	48.98%
Gross Profit	INR 2.2B
Gross Profit Growth	21.43%
Gross Profit Growth Q	49.22%
Gross Profit Growth3 Y	18.83%
Gross Profit Growth5 Y	12.52%
Net Income	INR 353.7M
Net Income Growth	8.51%
Net Income Growth Q	1,129.1%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	24.63%
Net Income Growth5 Y	-3.7%
Pretax Margin	10.48%
Profit Margin	7.92%
Profit Per Employee	INR 680,244
Profitable Years	18
Roa5y	11.55
Roe5y	21.41
ROIC	9.11
Roic5y	19.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	111.57%
Cagr3y	16.17%
EPS Growth	8.47
EPS Growth Q	1,127.1
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	24.63
EPS Growth5 Y	-3.71
Revenue Growth	19.85x
Revenue Growth Q	43.11x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	16.54x
Revenue Growth5 Y	15.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 558.9M
Debt	INR 882M
Debt EBITDA	INR 1.66
Debt Equity	INR 0.29
Equity	INR 3B
Interest Coverage	9.05
Net Cash	INR -323.2M
Net Cash By Market Cap	INR -2.23
Net Debt EBITDA	INR 0.61
Net Debt Equity	INR 0.11
Tangible Book Value	INR 3B
Tangible Book Value Per Share	INR 485
WACC	7.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1.75
Dividend Years	4
Dividend Yield	0.07%
Ex Div Date	2025-08-12
Last Dividend	INR 1.75

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	111.46%
200-day SMA	1,681.8
3Y total return	56.78%
50-day SMA	2,275.3
50-day SMA vs 200-day SMA	50over200
All Time High	2,823.9
All Time High Change	-16.25%
All Time High Date	2024-04-25
All Time Low	957
All Time Low Change	147.13%
All Time Low Date	2025-02-19
ATR	170.4
Beta	0.55
Ch YTD	68.18
High	2,656.6
High52	2,767.9
High52 Date	2026-05-06
High52ch	-14.56%
Low	2,283.1
Low52	980
Low52 Date	2025-06-20
Low52ch	141.33%
Ma50ch	3.94%
Price vs 200-day SMA	40.62%
RSI	51.18
RSI Monthly	61.38
RSI Weekly	67.19
Sharpe ratio	1.71x
Sortino ratio	2.99
Total Return	0.05%
Tr YTD	68.18
Tr1m	6.93%
Tr1w	4.69%
Tr3m	7.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 401M
Operating Income Growth	35.03
Operating Income Growth Q	757.6
Operating Income Growth3 Y	24.66
Operating Income Growth5 Y	-5.62
Operating margin	8.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,584,346%
Shares Insiders	65.97%
Shares Qo Q	-0.01%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	11,727.3x
Bv Per Share	485.9
Ch1m	6.93
Ch1w	4.69
Ch1y	111.2
Ch3m	7.97
Ch3y	56.3
Ch6m	59.21
Change	-10.98%
Change From Open	-10.08
Close	2,656.6
Days Gap	-1
Depreciation Amortization	129,105,250
Dollar Volume	86,485,685
Earnings Date	2026-05-22
EBIT	INR 401M
EBITDA	INR 530.1M
EPS	INR 57.25
F Score	2
Fiscal Year End	March
Founded	1,981
Graham Number	797.29661
Graham Upside	-66.29
Income Tax	INR 114.3M
Is Primary Listing	0
Last Earnings Date	2026-02-03
Last Report Date	2025-12-31
Lynch Fair Value	INR 288
Lynch Upside	-87.8
Ma150	1,785.8
Ma150ch	32.43%
Ma20	2,325.2
Ma20ch	1.71%
Next Earnings Date	2026-05-22
Open	2,630
Payment Date	2025-09-18
Position In Range	21.93
Price Date	2026-05-08
Price EBITDA	INR 27.35
Ptbv Ratio	4.84
Relative Volume	3.62x
Revenue	4,468,075,000x
Tax By Revenue	2.56x
Tax Rate	24.42%
Tr6m	59.21%
Volume	36,569

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/NGLFINE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$1.75 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.0%

Next ex-dividend date: 2025-08-12

Performance

NSE/NGLFINE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/NGLFINE?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+66.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/NGLFINE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.2

Neutral momentum band

Price vs 200-day MA

+40.6%

50/200-day relationship not available

Beta (5Y)

0.55

Less volatile than the market

Sharpe ratio

1.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/NGLFINE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/NGLFINE stock rating?

nse/NGLFINE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/NGLFINE analysis?

The full report lives at /stocks/nse/NGLFINE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/NGLFINE?

The latest report frames nse/NGLFINE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/NGLFINE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.